Performance Status Is a Predictive Factor of Improvement after Colonic Stenting in Patients with Malignant Stenosis due to Extraparenteral Malignant Tumors

Table 2

Patient and procedural characteristics.

Age	Sex	Primary cancer	Albumin (g/dL)	Location	Stent	Stenosis length (cm)	Stent length (mm)	Stent diameter (mm)	Chemotherapy	PS	CROSS (pre)	CROSS (post)	Adverse events
57	F	Breast	3.5	R	Wall	5	90	22	+	1	2	4	None
72	F	Breast	4.1	D	Niti-S	6	100	18	-	1	1	3	None
74	F	Breast	2.8	R	Niti-S	3	60	25	+	1	2	4	None
77	M	Stomach	2.2	T	Niti-S	5	100	18	-	2	2	3	None
86	F	Stomach	2.2	R	Wall	6	90	18	-	3	1	1	None
76	M	Stomach	3.1	R	Wall	6	120	18	-	1	1	3	None
59	F	Stomach	2.9	R	Wall	6	90	18	-	3	1	1	Perforation
81	F	Stomach	2.1	S	Niti-S	5	100	22	-	1	2	4	None
69	M	Stomach	3.4	S	Niti-S	6	100	18	-	3	1	3	None
84	M	Stomach	2.7	S	Niti-S	4	80	22	-	3	2	4	None
78	M	Stomach	2.6	R	Niti-S	6	100	22	-	2	1	3	None
56	F	Ovary	2.4	R	Niti-S	4	80	22	-	3	1	3	None
56	F	Ovary	2.8	R	Niti-S	4	80	18	-	3	1	1	None
52	F	Ovary	2.8	R	Niti-S	6	100	22	-	1	1	3	None
68	F	Ovary	3.1	S	Niti-S	6	100	18	-	1	1	3	None
74	F	Ovary	2.3	D	Niti-S	6	100	18	+	0	0	0	None
65	M	Pancreas	3.7	S	Niti-S	6	100	22	+	1	0	2	None
69	M	Pancreas	2.9	R	Wall	5	90	22	+	1	0	0	None
81	M	Urinary	3.4	S	Wall	6	120	22	+	1	1	1	None
73	M	Urinary	2.8	R	Wall	4	90	22	-	1	1	3	Hemorrhage
76	M	Urinary	4.2	D	Niti-S	4	80	22	-	1	1	4	None

PS: performance status; CROSS: colorectal obstruction scoring system; M: male; F: female; T: transverse colon; D: descending colon; S: sigmoid colon; R: rectum; Wall: WallFlex colonic stent (Boston Scientific Co., Ltd., MA, USA); Niti-S: Niti-S colonic stent (Taewoong Co., Ltd., Busan, Korea).